05/03/2025

In this talk, we will explore the utility and implementation of EndoPredict, a genomic test designed to provide accurate prognostic and predictive insights for patients with early-stage, ER+, HER2- breast cancer. The session will cover how EndoPredict aids clinicians in tailoring treatment strategies, identifying patients who may safely forgo chemotherapy, and improving long-term patient outcomes. Attendees will gain a deeper understanding of the test’s clinical validation, integration into current oncology practice, and its role in advancing precision medicine for breast cancer care.